Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Kadoma, OsakaFounded 19512,899 employeesWebsite
A major Japanese manufacturer specializing in generic medicines. It leverages formulation technology and quality management to support reliable medicine supply and more sustainable healthcare.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Domestic Pharmaceuticals Business | 79% | ¥217.0B | ¥27.1B | 12.5% |
| International Pharmaceuticals Business | 21% | ¥57.6B | ¥458M | 0.8% |
Close (Oct 30, 2026)
¥3,520+26.5% (1Y)
Towa +26.5% over 1Y, 14.5pt above the industry average (23 companies, +12.0%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥273.7B | ¥23.1B | ¥5.3B | ¥475.3B | — |
Sources: annual securities reports, earnings releases and other public disclosures (Jan 2026)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
